J
Jignesh Patel
Researcher at Cedars-Sinai Medical Center
Publications - 238
Citations - 6077
Jignesh Patel is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 29, co-authored 190 publications receiving 4445 citations.
Papers
More filters
Journal ArticleDOI
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo,Anne I. Dipchand,Randall C. Starling,Allen S. Anderson,Michael Chan,Shashank Desai,Savitri Fedson,Patrick W. Fisher,Gonzalo Gonzales-Stawinski,Luigi Martinelli,David C. McGiffin,Jon Smith,David O. Taylor,Bruno Meiser,Steven A. Webber,David A. Baran,Michael P. Carboni,Thomas J. Dengler,David L. Feldman,Maria Frigerio,Abdallah G. Kfoury,Daniel Kim,Jon A. Kobashigawa,Michael A. Shullo,Josef Stehlik,Jeffrey J. Teuteberg,Patricia A. Uber,Andreas Zuckermann,Sharon A. Hunt,Michael Burch,Geetha Bhat,Charles E. Canter,Richard E. Chinnock,Marisa G. Crespo-Leiro,Reynolds M. Delgado,Fabienne Dobbels,Kathleen L. Grady,W. Kao,Jaqueline Lamour,Gareth Parry,Jignesh Patel,Daniela Pini,Jeffrey A. Towbin,Gene Wolfel,Diego H. Delgado,Howard J. Eisen,Lee R. Goldberg,Jeff Hosenpud,Maryl R. Johnson,Anne Keogh,Clive Lewis,John B. O'Connell,Joseph G. Rogers,Heather J. Ross,Stuart D. Russell,Johan Vanhaecke,Amanda W. Rowe +56 more
TL;DR: Institutional Affiliations Chair Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA Task Force 1 Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Starlings R: University of Chicago, Chicago, Illinois,USA; Chan M: university of Alberta, Edmonton, Alberta, Canada ; Desai S: Inova Fairfax Hospital, Fairfax, Virginia, USA.
Journal ArticleDOI
Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients.
Richard Cheng,Rory Hachamovitch,Michelle M. Kittleson,Jignesh Patel,Francisco A. Arabia,Jaime Moriguchi,Fardad Esmailian,Babak Azarbal +7 more
TL;DR: Although ECMO can improve survival of patients with advanced heart disease, there is significant associated morbidity with performance of this intervention.
Journal ArticleDOI
Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
Jon A. Kobashigawa,Andreas Zuckermann,Peter S. Macdonald,Pascal Leprince,Fardad Esmailian,Minh B. Luu,Donna Mancini,Jignesh Patel,Rabia R. Razi,Hermann Reichenspurner,Stuart D. Russell,Javier Segovia,N. Smedira,Josef Stehlik,Florian Wagner +14 more
TL;DR: A consensus conference was organized to better define, diagnose, and manage primary graft dysfunction (PGD), with the aim of leading to better understanding of PGD and prevention/minimization of its adverse outcomes.
Journal ArticleDOI
Report from a consensus conference on antibody-mediated rejection in heart transplantation
Jon A. Kobashigawa,María G. Crespo-Leiro,Stephan M. Ensminger,Hermann Reichenspurner,Annalisa Angelini,Gerald J. Berry,Margaret Burke,Lawrence S.C. Czer,Nicola E. Hiemann,Abdallah G. Kfoury,Donna Mancini,Paul Mohacsi,Jignesh Patel,Naveen L. Pereira,Jeffrey L. Platt,Elaine F. Reed,Nancy L. Reinsmoen,E. Rene Rodriguez,Marlene L. Rose,Stuart D. Russell,Randy Starling,Nicole Suciu-Foca,Jose A. Tallaj,David O. Taylor,Adrian B. Van Bakel,Lori J. West,Adriana Zeevi,Andreas Zuckermann +27 more
TL;DR: A clinical definition for AMR (cardiac dysfunction and/or circulating donor-specific antibody) was no longer believed to be required due to recent publications demonstrating that asymptomatic (no cardiac dysfunction) biopsy-proven AMR is associated with subsequent greater mortality and greater development of cardiac allograft vasculopathy.
Journal ArticleDOI
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.
Daniel P. Judge,Stephen B. Heitner,Rodney H. Falk,Mathew S. Maurer,Sanjiv J. Shah,Ronald M. Witteles,Martha Grogan,Van N. Selby,Daniel Jacoby,Mazen Hanna,Jose Nativi-Nicolau,Jignesh Patel,Satish Rao,Uma Sinha,Cameron W. Turtle,Jonathan C. Fox +15 more
TL;DR: AG10 has the potential to be a safe and effective treatment for patients with ATTR-CM and a Phase 3 trial is planned.